192 related articles for article (PubMed ID: 15188082)
1. How to start antiretroviral therapy?
Horster S; Goebel FD
Infection; 2004 Jun; 32(3):184-5. PubMed ID: 15188082
[No Abstract] [Full Text] [Related]
2. Antiretroviral therapy in HIV-infected infants and children.
Marón G; Gaur AH; Flynn PM
Pediatr Infect Dis J; 2010 Apr; 29(4):360-3. PubMed ID: 20351530
[No Abstract] [Full Text] [Related]
3. The year in review: antiretroviral treatment.
Hirschel B; Opravil M
AIDS; 1999; 13 Suppl A():S177-87. PubMed ID: 10885775
[No Abstract] [Full Text] [Related]
4. Initial antiretroviral drugs.
Rojo P; Gonzalez-Tome MI; Ramos JT
Pediatr Infect Dis J; 2007 Dec; 26(12):1167; author reply 1167. PubMed ID: 18043466
[No Abstract] [Full Text] [Related]
5. [Non-nucleoside reverse transcriptase inhibitors. First line therapy].
MMW Fortschr Med; 2000; 142(3 Suppl):34-5. PubMed ID: 10893964
[No Abstract] [Full Text] [Related]
6. A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection.
Cardiello PG; Hassink E; Ananworanich J; Srasuebkul P; Samor T; Mahanontharit A; Ruxrungtham K; Hirschel B; Lange J; Phanuphak P; Cooper DA
Clin Infect Dis; 2005 Feb; 40(4):594-600. PubMed ID: 15712083
[TBL] [Abstract][Full Text] [Related]
7. Structured treatment interruption.
Boyle BA
AIDS Read; 2000 May; 10(5):259-62. PubMed ID: 10851712
[No Abstract] [Full Text] [Related]
8. [HIV-infection: modern antiretroviral therapy].
Rockstroh JK; Spengler U
Dtsch Med Wochenschr; 2004 Sep; 129(37):1921-4. PubMed ID: 15372371
[No Abstract] [Full Text] [Related]
9. Nucleoside analogues in 2008.
Warwick Z; Churchill D
J HIV Ther; 2008 Mar; 13(1):3-8. PubMed ID: 18953267
[No Abstract] [Full Text] [Related]
10. Key clinical trials of non-nucleoside reverse transcriptase inhibitors in the treatment of chronic HIV-1 infection in adults.
Williams I
J HIV Ther; 2008 Mar; 13(1):19-23. PubMed ID: 18953269
[No Abstract] [Full Text] [Related]
11. HIV-1 genotype after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy and virological response after resumption of the same regimen.
Sungkanuparph S; Kiertiburanakul S; Apisarnthanarak A; Malathum K; Sathapatayavongs B
Int J STD AIDS; 2007 Dec; 18(12):832-4. PubMed ID: 18073016
[TBL] [Abstract][Full Text] [Related]
12. The current role of ritonavir-boosted protease inhibitors in the management of HIV infection.
Wilkins E
J HIV Ther; 2008 Mar; 13(1):9-18. PubMed ID: 18953268
[No Abstract] [Full Text] [Related]
13. Adherence to combination antiretroviral therapy assessed by anonymous patient self-report.
Walsh JC; Dalton M; Gazzard BG
AIDS; 1998 Dec; 12(17):2361-3. PubMed ID: 9863888
[No Abstract] [Full Text] [Related]
14. Immunovirologic consequences and safety of short, non-structured interruptions of successful antiretroviral treatment.
Sanchez R; Portilla J; Gimeno A; Boix V; Llopis C; Sanchez-Paya J; Merino E; de la Sen ML; Muñoz C; Reus S; Plazas J
J Infect; 2007 Feb; 54(2):159-66. PubMed ID: 16690132
[TBL] [Abstract][Full Text] [Related]
15. [New variations in highly active antiretroviral therapy. Simple combination as a promising option].
MMW Fortschr Med; 2000 Mar; 142 Suppl 1():50-2. PubMed ID: 10863312
[No Abstract] [Full Text] [Related]
16. Controversies in current treatment guidelines.
Gazzard BG
J HIV Ther; 2008 Mar; 13(1):1-3. PubMed ID: 18953266
[No Abstract] [Full Text] [Related]
17. Stavudine, lamivudine plus novel protease inhibitor therapy in antiretroviral-naive HIV-infected individuals treated for 24 weeks.
Murphy RL
Antivir Ther; 1999; 4 Suppl 3():85-7. PubMed ID: 16021877
[TBL] [Abstract][Full Text] [Related]
18. Virological and pharmacological factors associated with virological response to salvage therapy after an 8-week of treatment interruption in a context of very advanced HIV disease (GigHAART ANRS 097).
Delaugerre C; Peytavin G; Dominguez S; Marcelin AG; Duvivier C; Gourlain K; Amellal B; Legrand M; Raffi F; Costagliola D; Katlama C; Calvez V
J Med Virol; 2005 Nov; 77(3):345-50. PubMed ID: 16173015
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome of long-term lamivudine treated chronic HBV infected and HIV/HBV coinfected patients.
Elefsiniotis IS; Paparizos V; Dourakis SP; Mpotsi C; Pantazis KD; Katsambas N
J Clin Virol; 2005 May; 33(1):80-2. PubMed ID: 15797371
[No Abstract] [Full Text] [Related]
20. Alternation of antiretroviral drug regimens for HIV infection. Efficacy, safety and tolerability at week 96 of the Swatch Study.
Negredo E; Paredes R; Peraire J; Pedrol E; Côté H; Gel S; Fumoz CR; Ruiz L; Abril V; Rodriguez de Castro E; Ochoa C; Martinez-Picado J; Montaner J; Rey-Joly C; Clotet B;
Antivir Ther; 2004 Dec; 9(6):889-93. PubMed ID: 15651747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
